Bayesian Phase Iii Trials

Bayesian Phase III Trials is a type of confirmatory clinical trial design that employs Bayesian statistical methods to dynamically update evidence about treatment efficacy and safety during the trial, distinguishing it from traditional frequentist Phase III trials by incorporating prior knowledge and enabling probabilistic decision-making about treatment success or futility.

33

Publications

856

Citations

131

Authors

96

Institutions

Publications per year

2017–2026

14

Authors

131

  1. ER
    Elizabeth Ryan

    King's College London, United Kingdom

    3 publications · 98 citations

    3

    h-index

  2. SG
    Simon Gates

    University of Warwick, United Kingdom

    3 publications · 98 citations

    3

    h-index

  3. SC
    Sylvie Chevret

    Hôpital Saint-Louis, France

    2 publications · 68 citations

    2

    h-index

  4. SE
    Sarah E Lamb

    University of Oxford, United Kingdom

    2 publications · 82 citations

    2

    h-index

  5. DA
    Donald A. Berry

    The University of Texas MD Anderson Cancer Center, United States

    2 publications · 147 citations

    2

    h-index

1–5 of 131

Venues

  1. Statistics in Medicine

    8 publications · 208 citations

    8

    h-index

  2. Pharmaceutical Statistics

    3 publications · 56 citations

    3

    h-index

  3. Trials

    2 publications · 54 citations

    2

    h-index

  4. Clinical Trials

    2 publications · 26 citations

    2

    h-index

  5. Biometrics

    2 publications · 154 citations

    2

    h-index

1–5